标普和纳斯达克内在价值 联系我们

Qilian International Holding Group Limited QLI NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CN • USD

SharesGrow Score
40/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Qilian International Holding Group Limited (QLI) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 38/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
~
过去
75/100
→ Income
健康
100/100
Debt-to-Equity & liquidity
→ Health
护城河
0/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — QLI

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率4.16
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.22
每股账面价值$0.00
每股营收$1.30
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2017 $0.04 $22.54M $1.41M 6.3%
2018 $0.15 $50.37M $5.17M 10.3%
2019 $0.15 $46.1M $5.33M 11.6%
2020 $0.14 $50.03M $5.06M 10.1%
2021 $0.09 $57.1M $3.15M 5.5%
2022 $0.03 $64.86M $1.08M 1.7%
2023 $-0.22 $46.47M $-7.78M -16.7%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言